Kyphoplasty Market By Product (Kyphoplasty Systems, Accessories), By Indication (Osteoporosis, Others), By End User (Hospitals and Clinics, Ambulatory Surgical Centers): Global Opportunity Analysis and Industry Forecast, 2021-2031
The global kyphoplasty market was valued at $632.45 million in 2021, and is estimated to reach $1,154.82 million by 2031, growing at a CAGR of 6.2% from 2022 to 2031.
Kyphoplasty is a surgical procedure that expands and stabilizes spinal compression fractures. Its uses involve injecting a specific cement into vertebrae, by using a balloon-like device to create space for the procedure. Kyphoplasty is a modification of vertebroplasty that helps restore the height of a damaged vertebra as well as eases discomfort. It is one of the procedures adopted for treating vertebral body compression fractures, which are minor breaks in the dense mass of bone that makes up the front section of the spinal cord.
The major factors that drive the growth of the kyphoplasty market is the increase in geriatric population, rise in incidence of osteoporosis & arthritis, increase in the prevalence of spine disorders, and growth in patient awareness about advancements in spine surgeries, are the factors attributed to the growth of the kyphoplasty market. In addition, shift toward minimally invasive spine surgeries is a key trend of the market, which is expected to fuel the growth during the forecast period.
Significant surge in the geriatric population is one leading factors of this market as aging leads to reduced bone density, which is influenced by a variety of variables such as lifestyle, diet, physical activity (PA), smoking, alcohol use, chronic illness conditions, and medication. Aging causes a number of physiological changes that might result in illnesses like osteoporosis, thus raising the chance of bone fractures, which can lower one's quality of life. For instance, according to the International Osteoporosis Foundation, each year, osteoporosis causes more than 8.9 million fractures, with one occurring every three seconds. It affects roughly 6.3% of males over 50 and 21.2% of women in the same age range across the world, affecting approximately 500 million men and women. Thus, such high number of cases are expected to boost the kyphoplasty procedures.
In addition, upsurge in the cases of back pain, especially among women, adoption of sedentary lifestyles, lower physical activity are some risk factors that may lead to uptake of such procedures. However, unfavorable reimbursements scenarios and risks associated with post-surgical complications are expected to hinder the growth of the market. Conversely, technological advancements for minimally invasive procedures and launch of kyphoplasty products to suffice the consumer demands in developing countries is expected to provide a great opportunity for the investors to invest in the market. For instance, Medtronic in May 2020, announced the U.S. launch of Kyphon Assist Directional Cannula for use with its balloon kyphoplasty (BKP) products to treat vertebral compression fractures due to osteoporosis, cancer or benign lesions.
The global kyphoplasty market is segmented on the basis of product, indication, end user, and region. On the basis of product, the market is categorized into kyphoplasty systems and accessories. By indication, it is segmented into osteoporosis and others. By end user, it is segmented into hospital & clinics and ambulatory surgical centers. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and Latin America, the Middle East, and Africa (LAMEA).
The major players profiled in the report are Alphatec Holdings Inc., Benvenue Medical Inc., Globus Medical Inc., IZI Medical Products, Johnson and Johnson, Medtronic Plc., Merit Medicals Systems, Stryker Corporation, Seawon Meditech and Zimmer Biomet Holdings, Inc.
KEY BENEFITS FOR STAKEHOLDERS
This report provides an extensive analysis of the current and emerging market trends and dynamics in the global kyphoplasty market to identify the prevailing opportunities.
This study presents the competitive landscape of the global market to predict the competitive environment across geographies.
Comprehensive analysis of factors that drive and restrict the market growth is provided.
Region- & country-wise analysis is provided to understand the market trends and dynamics.
Key Market Segments
By Product
Kyphoplasty Systems
Accessories
By Indication
Osteoporosis
Others
By End User
Hospitals and Clinics
Ambulatory Surgical Centers
By Region
North America
U.S.
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Rest of Europe
Asia-Pacific
Japan
China
Australia
India
South Korea
Rest of Asia-Pacific
LAMEA
Brazil
Saudi Arabia
South Africa
Rest of LAMEA
Key Market Players
Alphatec Holdings TNC
Benvenue Medical Inc
Globul Medical Inc
Jhonson and Jhonson
Medtronic
Stryker
IZI Medica Products
Merit Medicals Systems
Swawon Meditech
Please Note: It will take 7-10 business days to complete the report upon order confirmation.
- CHAPTER 1:INTRODUCTION
- 1.1.Report description
- 1.2.Key market segments
- 1.3.Key benefits to the stakeholders
- 1.4.Research Methodology
- 1.4.1.Secondary research
- 1.4.2.Primary research
- 1.4.3.Analyst tools and models
- CHAPTER 2:EXECUTIVE SUMMARY
- 2.1.Key findings of the study
- 2.2.CXO Perspective
- CHAPTER 3:MARKET OVERVIEW
- 3.1.Market definition and scope
- 3.2.Key findings
- 3.2.1.Top investment pockets
- 3.3.Porter’s five forces analysis
- 3.4.Top player positioning
- 3.5.Market dynamics
- 3.5.1.Drivers
- 3.5.2.Restraints
- 3.5.3.Opportunities
- 3.6.COVID-19 Impact Analysis on the market
- CHAPTER 4: KYPHOPLASTY MARKET, BY PRODUCT
- 4.1 Overview
- 4.1.1 Market size and forecast
- 4.2 Kyphoplasty Systems
- 4.2.1 Key market trends, growth factors and opportunities
- 4.2.2 Market size and forecast, by region
- 4.2.3 Market analysis by country
- 4.3 Accessories
- 4.3.1 Key market trends, growth factors and opportunities
- 4.3.2 Market size and forecast, by region
- 4.3.3 Market analysis by country
- CHAPTER 5: KYPHOPLASTY MARKET, BY INDICATION
- 5.1 Overview
- 5.1.1 Market size and forecast
- 5.2 Osteoporosis
- 5.2.1 Key market trends, growth factors and opportunities
- 5.2.2 Market size and forecast, by region
- 5.2.3 Market analysis by country
- 5.3 Others
- 5.3.1 Key market trends, growth factors and opportunities
- 5.3.2 Market size and forecast, by region
- 5.3.3 Market analysis by country
- CHAPTER 6: KYPHOPLASTY MARKET, BY END USER
- 6.1 Overview
- 6.1.1 Market size and forecast
- 6.2 Hospitals and Clinics
- 6.2.1 Key market trends, growth factors and opportunities
- 6.2.2 Market size and forecast, by region
- 6.2.3 Market analysis by country
- 6.3 Ambulatory Surgical Centers
- 6.3.1 Key market trends, growth factors and opportunities
- 6.3.2 Market size and forecast, by region
- 6.3.3 Market analysis by country
- CHAPTER 7: KYPHOPLASTY MARKET, BY REGION
- 7.1 Overview
- 7.1.1 Market size and forecast
- 7.2 North America
- 7.2.1 Key trends and opportunities
- 7.2.2 North America Market size and forecast, by Product
- 7.2.3 North America Market size and forecast, by Indication
- 7.2.4 North America Market size and forecast, by End User
- 7.2.5 North America Market size and forecast, by country
- 7.2.5.1 U.S.
- 7.2.5.1.1 Market size and forecast, by Product
- 7.2.5.1.2 Market size and forecast, by Indication
- 7.2.5.1.3 Market size and forecast, by End User
- 7.2.5.2 Canada
- 7.2.5.2.1 Market size and forecast, by Product
- 7.2.5.2.2 Market size and forecast, by Indication
- 7.2.5.2.3 Market size and forecast, by End User
- 7.2.5.3 Mexico
- 7.2.5.3.1 Market size and forecast, by Product
- 7.2.5.3.2 Market size and forecast, by Indication
- 7.2.5.3.3 Market size and forecast, by End User
- 7.3 Europe
- 7.3.1 Key trends and opportunities
- 7.3.2 Europe Market size and forecast, by Product
- 7.3.3 Europe Market size and forecast, by Indication
- 7.3.4 Europe Market size and forecast, by End User
- 7.3.5 Europe Market size and forecast, by country
- 7.3.5.1 Germany
- 7.3.5.1.1 Market size and forecast, by Product
- 7.3.5.1.2 Market size and forecast, by Indication
- 7.3.5.1.3 Market size and forecast, by End User
- 7.3.5.2 France
- 7.3.5.2.1 Market size and forecast, by Product
- 7.3.5.2.2 Market size and forecast, by Indication
- 7.3.5.2.3 Market size and forecast, by End User
- 7.3.5.3 U.K.
- 7.3.5.3.1 Market size and forecast, by Product
- 7.3.5.3.2 Market size and forecast, by Indication
- 7.3.5.3.3 Market size and forecast, by End User
- 7.3.5.4 Italy
- 7.3.5.4.1 Market size and forecast, by Product
- 7.3.5.4.2 Market size and forecast, by Indication
- 7.3.5.4.3 Market size and forecast, by End User
- 7.3.5.5 Spain
- 7.3.5.5.1 Market size and forecast, by Product
- 7.3.5.5.2 Market size and forecast, by Indication
- 7.3.5.5.3 Market size and forecast, by End User
- 7.3.5.6 Rest of Europe
- 7.3.5.6.1 Market size and forecast, by Product
- 7.3.5.6.2 Market size and forecast, by Indication
- 7.3.5.6.3 Market size and forecast, by End User
- 7.4 Asia-Pacific
- 7.4.1 Key trends and opportunities
- 7.4.2 Asia-Pacific Market size and forecast, by Product
- 7.4.3 Asia-Pacific Market size and forecast, by Indication
- 7.4.4 Asia-Pacific Market size and forecast, by End User
- 7.4.5 Asia-Pacific Market size and forecast, by country
- 7.4.5.1 Japan
- 7.4.5.1.1 Market size and forecast, by Product
- 7.4.5.1.2 Market size and forecast, by Indication
- 7.4.5.1.3 Market size and forecast, by End User
- 7.4.5.2 China
- 7.4.5.2.1 Market size and forecast, by Product
- 7.4.5.2.2 Market size and forecast, by Indication
- 7.4.5.2.3 Market size and forecast, by End User
- 7.4.5.3 Australia
- 7.4.5.3.1 Market size and forecast, by Product
- 7.4.5.3.2 Market size and forecast, by Indication
- 7.4.5.3.3 Market size and forecast, by End User
- 7.4.5.4 India
- 7.4.5.4.1 Market size and forecast, by Product
- 7.4.5.4.2 Market size and forecast, by Indication
- 7.4.5.4.3 Market size and forecast, by End User
- 7.4.5.5 South Korea
- 7.4.5.5.1 Market size and forecast, by Product
- 7.4.5.5.2 Market size and forecast, by Indication
- 7.4.5.5.3 Market size and forecast, by End User
- 7.4.5.6 Rest of Asia-Pacific
- 7.4.5.6.1 Market size and forecast, by Product
- 7.4.5.6.2 Market size and forecast, by Indication
- 7.4.5.6.3 Market size and forecast, by End User
- 7.5 LAMEA
- 7.5.1 Key trends and opportunities
- 7.5.2 LAMEA Market size and forecast, by Product
- 7.5.3 LAMEA Market size and forecast, by Indication
- 7.5.4 LAMEA Market size and forecast, by End User
- 7.5.5 LAMEA Market size and forecast, by country
- 7.5.5.1 Brazil
- 7.5.5.1.1 Market size and forecast, by Product
- 7.5.5.1.2 Market size and forecast, by Indication
- 7.5.5.1.3 Market size and forecast, by End User
- 7.5.5.2 Saudi Arabia
- 7.5.5.2.1 Market size and forecast, by Product
- 7.5.5.2.2 Market size and forecast, by Indication
- 7.5.5.2.3 Market size and forecast, by End User
- 7.5.5.3 South Africa
- 7.5.5.3.1 Market size and forecast, by Product
- 7.5.5.3.2 Market size and forecast, by Indication
- 7.5.5.3.3 Market size and forecast, by End User
- 7.5.5.4 Rest of LAMEA
- 7.5.5.4.1 Market size and forecast, by Product
- 7.5.5.4.2 Market size and forecast, by Indication
- 7.5.5.4.3 Market size and forecast, by End User
- CHAPTER 8: COMPANY LANDSCAPE
- 8.1. Introduction
- 8.2. Top winning strategies
- 8.3. Product Mapping of Top 10 Player
- 8.4. Competitive Dashboard
- 8.5. Competitive Heatmap
- 8.6. Key developments
- CHAPTER 9: COMPANY PROFILES
- 9.1 Alphatec Holdings TNC
- 9.1.1 Company overview
- 9.1.2 Company snapshot
- 9.1.3 Operating business segments
- 9.1.4 Product portfolio
- 9.1.5 Business performance
- 9.1.6 Key strategic moves and developments
- 9.2 Benvenue Medical Inc
- 9.2.1 Company overview
- 9.2.2 Company snapshot
- 9.2.3 Operating business segments
- 9.2.4 Product portfolio
- 9.2.5 Business performance
- 9.2.6 Key strategic moves and developments
- 9.3 Globul Medical Inc
- 9.3.1 Company overview
- 9.3.2 Company snapshot
- 9.3.3 Operating business segments
- 9.3.4 Product portfolio
- 9.3.5 Business performance
- 9.3.6 Key strategic moves and developments
- 9.4 Jhonson and Jhonson
- 9.4.1 Company overview
- 9.4.2 Company snapshot
- 9.4.3 Operating business segments
- 9.4.4 Product portfolio
- 9.4.5 Business performance
- 9.4.6 Key strategic moves and developments
- 9.5 Medtronic
- 9.5.1 Company overview
- 9.5.2 Company snapshot
- 9.5.3 Operating business segments
- 9.5.4 Product portfolio
- 9.5.5 Business performance
- 9.5.6 Key strategic moves and developments
- 9.6 Stryker
- 9.6.1 Company overview
- 9.6.2 Company snapshot
- 9.6.3 Operating business segments
- 9.6.4 Product portfolio
- 9.6.5 Business performance
- 9.6.6 Key strategic moves and developments
- 9.7 IZI Medica Products
- 9.7.1 Company overview
- 9.7.2 Company snapshot
- 9.7.3 Operating business segments
- 9.7.4 Product portfolio
- 9.7.5 Business performance
- 9.7.6 Key strategic moves and developments
- 9.8 Merit Medicals Systems
- 9.8.1 Company overview
- 9.8.2 Company snapshot
- 9.8.3 Operating business segments
- 9.8.4 Product portfolio
- 9.8.5 Business performance
- 9.8.6 Key strategic moves and developments
- 9.9 Swawon Meditech
- 9.9.1 Company overview
- 9.9.2 Company snapshot
- 9.9.3 Operating business segments
- 9.9.4 Product portfolio
- 9.9.5 Business performance
- 9.9.6 Key strategic moves and developments
- LIST OF TABLES
- TABLE 1. GLOBAL KYPHOPLASTY MARKET, BY PRODUCT, 2021-2031,($MILLION)
- TABLE 2. KYPHOPLASTY MARKET REVENUE, FOR KYPHOPLASTY SYSTEMS, BY REGION , 2021-2031,($MILLION)
- TABLE 3. KYPHOPLASTY MARKET FOR KYPHOPLASTY SYSTEMS BY COUNTRY, 2021-2031,($MILLION)
- TABLE 4. KYPHOPLASTY MARKET REVENUE, FOR ACCESSORIES, BY REGION , 2021-2031,($MILLION)
- TABLE 5. KYPHOPLASTY MARKET FOR ACCESSORIES BY COUNTRY, 2021-2031,($MILLION)
- TABLE 6. GLOBAL KYPHOPLASTY MARKET, BY INDICATION, 2021-2031,($MILLION)
- TABLE 7. KYPHOPLASTY MARKET REVENUE, FOR OSTEOPOROSIS, BY REGION , 2021-2031,($MILLION)
- TABLE 8. KYPHOPLASTY MARKET FOR OSTEOPOROSIS BY COUNTRY, 2021-2031,($MILLION)
- TABLE 9. KYPHOPLASTY MARKET REVENUE, FOR OTHERS, BY REGION , 2021-2031,($MILLION)
- TABLE 10. KYPHOPLASTY MARKET FOR OTHERS BY COUNTRY, 2021-2031,($MILLION)
- TABLE 11. GLOBAL KYPHOPLASTY MARKET, BY END USER, 2021-2031,($MILLION)
- TABLE 12. KYPHOPLASTY MARKET REVENUE, FOR HOSPITALS AND CLINICS, BY REGION , 2021-2031,($MILLION)
- TABLE 13. KYPHOPLASTY MARKET FOR HOSPITALS AND CLINICS BY COUNTRY, 2021-2031,($MILLION)
- TABLE 14. KYPHOPLASTY MARKET REVENUE, FOR AMBULATORY SURGICAL CENTERS, BY REGION , 2021-2031,($MILLION)
- TABLE 15. KYPHOPLASTY MARKET FOR AMBULATORY SURGICAL CENTERS BY COUNTRY, 2021-2031,($MILLION)
- TABLE 16. KYPHOPLASTY MARKET, BY REGION, 2021-2031,($MILLION)
- TABLE 17. NORTH AMERICA KYPHOPLASTY MARKET, BY PRODUCT, 2021-2031,($MILLION)
- TABLE 18. NORTH AMERICA KYPHOPLASTY MARKET, BY INDICATION, 2021-2031,($MILLION)
- TABLE 19. NORTH AMERICA KYPHOPLASTY MARKET, BY END USER, 2021-2031,($MILLION)
- TABLE 20. NORTH AMERICA KYPHOPLASTY MARKET, BY COUNTRY, 2021-2031,($MILLION)
- TABLE 21. U.S. KYPHOPLASTY MARKET, BY PRODUCT, 2021-2031,($MILLION)
- TABLE 22. U.S. KYPHOPLASTY MARKET, BY INDICATION, 2021-2031,($MILLION)
- TABLE 23. U.S. KYPHOPLASTY MARKET, BY END USER, 2021-2031,($MILLION)
- TABLE 24. CANADA KYPHOPLASTY MARKET, BY PRODUCT, 2021-2031,($MILLION)
- TABLE 25. CANADA KYPHOPLASTY MARKET, BY INDICATION, 2021-2031,($MILLION)
- TABLE 26. CANADA KYPHOPLASTY MARKET, BY END USER, 2021-2031,($MILLION)
- TABLE 27. MEXICO KYPHOPLASTY MARKET, BY PRODUCT, 2021-2031,($MILLION)
- TABLE 28. MEXICO KYPHOPLASTY MARKET, BY INDICATION, 2021-2031,($MILLION)
- TABLE 29. MEXICO KYPHOPLASTY MARKET, BY END USER, 2021-2031,($MILLION)
- TABLE 30. EUROPE KYPHOPLASTY MARKET, BY PRODUCT, 2021-2031,($MILLION)
- TABLE 31. EUROPE KYPHOPLASTY MARKET, BY INDICATION, 2021-2031,($MILLION)
- TABLE 32. EUROPE KYPHOPLASTY MARKET, BY END USER, 2021-2031,($MILLION)
- TABLE 33. EUROPE KYPHOPLASTY MARKET, BY COUNTRY, 2021-2031,($MILLION)
- TABLE 34. GERMANY KYPHOPLASTY MARKET, BY PRODUCT, 2021-2031,($MILLION)
- TABLE 35. GERMANY KYPHOPLASTY MARKET, BY INDICATION, 2021-2031,($MILLION)
- TABLE 36. GERMANY KYPHOPLASTY MARKET, BY END USER, 2021-2031,($MILLION)
- TABLE 37. FRANCE KYPHOPLASTY MARKET, BY PRODUCT, 2021-2031,($MILLION)
- TABLE 38. FRANCE KYPHOPLASTY MARKET, BY INDICATION, 2021-2031,($MILLION)
- TABLE 39. FRANCE KYPHOPLASTY MARKET, BY END USER, 2021-2031,($MILLION)
- TABLE 40. U.K. KYPHOPLASTY MARKET, BY PRODUCT, 2021-2031,($MILLION)
- TABLE 41. U.K. KYPHOPLASTY MARKET, BY INDICATION, 2021-2031,($MILLION)
- TABLE 42. U.K. KYPHOPLASTY MARKET, BY END USER, 2021-2031,($MILLION)
- TABLE 43. ITALY KYPHOPLASTY MARKET, BY PRODUCT, 2021-2031,($MILLION)
- TABLE 44. ITALY KYPHOPLASTY MARKET, BY INDICATION, 2021-2031,($MILLION)
- TABLE 45. ITALY KYPHOPLASTY MARKET, BY END USER, 2021-2031,($MILLION)
- TABLE 46. SPAIN KYPHOPLASTY MARKET, BY PRODUCT, 2021-2031,($MILLION)
- TABLE 47. SPAIN KYPHOPLASTY MARKET, BY INDICATION, 2021-2031,($MILLION)
- TABLE 48. SPAIN KYPHOPLASTY MARKET, BY END USER, 2021-2031,($MILLION)
- TABLE 49. REST OF EUROPE KYPHOPLASTY MARKET, BY PRODUCT, 2021-2031,($MILLION)
- TABLE 50. REST OF EUROPE KYPHOPLASTY MARKET, BY INDICATION, 2021-2031,($MILLION)
- TABLE 51. REST OF EUROPE KYPHOPLASTY MARKET, BY END USER, 2021-2031,($MILLION)
- TABLE 52. ASIA-PACIFIC KYPHOPLASTY MARKET, BY PRODUCT, 2021-2031,($MILLION)
- TABLE 53. ASIA-PACIFIC KYPHOPLASTY MARKET, BY INDICATION, 2021-2031,($MILLION)
- TABLE 54. ASIA-PACIFIC KYPHOPLASTY MARKET, BY END USER, 2021-2031,($MILLION)
- TABLE 55. ASIA-PACIFIC KYPHOPLASTY MARKET, BY COUNTRY, 2021-2031,($MILLION)
- TABLE 56. JAPAN KYPHOPLASTY MARKET, BY PRODUCT, 2021-2031,($MILLION)
- TABLE 57. JAPAN KYPHOPLASTY MARKET, BY INDICATION, 2021-2031,($MILLION)
- TABLE 58. JAPAN KYPHOPLASTY MARKET, BY END USER, 2021-2031,($MILLION)
- TABLE 59. CHINA KYPHOPLASTY MARKET, BY PRODUCT, 2021-2031,($MILLION)
- TABLE 60. CHINA KYPHOPLASTY MARKET, BY INDICATION, 2021-2031,($MILLION)
- TABLE 61. CHINA KYPHOPLASTY MARKET, BY END USER, 2021-2031,($MILLION)
- TABLE 62. AUSTRALIA KYPHOPLASTY MARKET, BY PRODUCT, 2021-2031,($MILLION)
- TABLE 63. AUSTRALIA KYPHOPLASTY MARKET, BY INDICATION, 2021-2031,($MILLION)
- TABLE 64. AUSTRALIA KYPHOPLASTY MARKET, BY END USER, 2021-2031,($MILLION)
- TABLE 65. INDIA KYPHOPLASTY MARKET, BY PRODUCT, 2021-2031,($MILLION)
- TABLE 66. INDIA KYPHOPLASTY MARKET, BY INDICATION, 2021-2031,($MILLION)
- TABLE 67. INDIA KYPHOPLASTY MARKET, BY END USER, 2021-2031,($MILLION)
- TABLE 68. SOUTH KOREA KYPHOPLASTY MARKET, BY PRODUCT, 2021-2031,($MILLION)
- TABLE 69. SOUTH KOREA KYPHOPLASTY MARKET, BY INDICATION, 2021-2031,($MILLION)
- TABLE 70. SOUTH KOREA KYPHOPLASTY MARKET, BY END USER, 2021-2031,($MILLION)
- TABLE 71. REST OF ASIA-PACIFIC KYPHOPLASTY MARKET, BY PRODUCT, 2021-2031,($MILLION)
- TABLE 72. REST OF ASIA-PACIFIC KYPHOPLASTY MARKET, BY INDICATION, 2021-2031,($MILLION)
- TABLE 73. REST OF ASIA-PACIFIC KYPHOPLASTY MARKET, BY END USER, 2021-2031,($MILLION)
- TABLE 74. LAMEA KYPHOPLASTY MARKET, BY PRODUCT, 2021-2031,($MILLION)
- TABLE 75. LAMEA KYPHOPLASTY MARKET, BY INDICATION, 2021-2031,($MILLION)
- TABLE 76. LAMEA KYPHOPLASTY MARKET, BY END USER, 2021-2031,($MILLION)
- TABLE 77. LAMEA KYPHOPLASTY MARKET, BY COUNTRY, 2021-2031,($MILLION)
- TABLE 78. BRAZIL KYPHOPLASTY MARKET, BY PRODUCT, 2021-2031,($MILLION)
- TABLE 79. BRAZIL KYPHOPLASTY MARKET, BY INDICATION, 2021-2031,($MILLION)
- TABLE 80. BRAZIL KYPHOPLASTY MARKET, BY END USER, 2021-2031,($MILLION)
- TABLE 81. SAUDI ARABIA KYPHOPLASTY MARKET, BY PRODUCT, 2021-2031,($MILLION)
- TABLE 82. SAUDI ARABIA KYPHOPLASTY MARKET, BY INDICATION, 2021-2031,($MILLION)
- TABLE 83. SAUDI ARABIA KYPHOPLASTY MARKET, BY END USER, 2021-2031,($MILLION)
- TABLE 84. SOUTH AFRICA KYPHOPLASTY MARKET, BY PRODUCT, 2021-2031,($MILLION)
- TABLE 85. SOUTH AFRICA KYPHOPLASTY MARKET, BY INDICATION, 2021-2031,($MILLION)
- TABLE 86. SOUTH AFRICA KYPHOPLASTY MARKET, BY END USER, 2021-2031,($MILLION)
- TABLE 87. REST OF LAMEA KYPHOPLASTY MARKET, BY PRODUCT, 2021-2031,($MILLION)
- TABLE 88. REST OF LAMEA KYPHOPLASTY MARKET, BY INDICATION, 2021-2031,($MILLION)
- TABLE 89. REST OF LAMEA KYPHOPLASTY MARKET, BY END USER, 2021-2031,($MILLION)
- TABLE 90.ALPHATEC HOLDINGS TNC: COMPANY SNAPSHOT
- TABLE 91.ALPHATEC HOLDINGS TNC: OPERATING SEGMENTS
- TABLE 92.ALPHATEC HOLDINGS TNC: PRODUCT PORTFOLIO
- TABLE 93.ALPHATEC HOLDINGS TNC: NET SALES,
- TABLE 94.ALPHATEC HOLDINGS TNC: KEY STRATERGIES
- TABLE 95.BENVENUE MEDICAL INC: COMPANY SNAPSHOT
- TABLE 96.BENVENUE MEDICAL INC: OPERATING SEGMENTS
- TABLE 97.BENVENUE MEDICAL INC: PRODUCT PORTFOLIO
- TABLE 98.BENVENUE MEDICAL INC: NET SALES,
- TABLE 99.BENVENUE MEDICAL INC: KEY STRATERGIES
- TABLE 100.GLOBUL MEDICAL INC: COMPANY SNAPSHOT
- TABLE 101.GLOBUL MEDICAL INC: OPERATING SEGMENTS
- TABLE 102.GLOBUL MEDICAL INC: PRODUCT PORTFOLIO
- TABLE 103.GLOBUL MEDICAL INC: NET SALES,
- TABLE 104.GLOBUL MEDICAL INC: KEY STRATERGIES
- TABLE 105.JHONSON AND JHONSON: COMPANY SNAPSHOT
- TABLE 106.JHONSON AND JHONSON: OPERATING SEGMENTS
- TABLE 107.JHONSON AND JHONSON: PRODUCT PORTFOLIO
- TABLE 108.JHONSON AND JHONSON: NET SALES,
- TABLE 109.JHONSON AND JHONSON: KEY STRATERGIES
- TABLE 110.MEDTRONIC: COMPANY SNAPSHOT
- TABLE 111.MEDTRONIC: OPERATING SEGMENTS
- TABLE 112.MEDTRONIC: PRODUCT PORTFOLIO
- TABLE 113.MEDTRONIC: NET SALES,
- TABLE 114.MEDTRONIC: KEY STRATERGIES
- TABLE 115.STRYKER: COMPANY SNAPSHOT
- TABLE 116.STRYKER: OPERATING SEGMENTS
- TABLE 117.STRYKER: PRODUCT PORTFOLIO
- TABLE 118.STRYKER: NET SALES,
- TABLE 119.STRYKER: KEY STRATERGIES
- TABLE 120.IZI MEDICA PRODUCTS: COMPANY SNAPSHOT
- TABLE 121.IZI MEDICA PRODUCTS: OPERATING SEGMENTS
- TABLE 122.IZI MEDICA PRODUCTS: PRODUCT PORTFOLIO
- TABLE 123.IZI MEDICA PRODUCTS: NET SALES,
- TABLE 124.IZI MEDICA PRODUCTS: KEY STRATERGIES
- TABLE 125.MERIT MEDICALS SYSTEMS: COMPANY SNAPSHOT
- TABLE 126.MERIT MEDICALS SYSTEMS: OPERATING SEGMENTS
- TABLE 127.MERIT MEDICALS SYSTEMS: PRODUCT PORTFOLIO
- TABLE 128.MERIT MEDICALS SYSTEMS: NET SALES,
- TABLE 129.MERIT MEDICALS SYSTEMS: KEY STRATERGIES
- TABLE 130.SWAWON MEDITECH: COMPANY SNAPSHOT
- TABLE 131.SWAWON MEDITECH: OPERATING SEGMENTS
- TABLE 132.SWAWON MEDITECH: PRODUCT PORTFOLIO
- TABLE 133.SWAWON MEDITECH: NET SALES,
- TABLE 134.SWAWON MEDITECH: KEY STRATERGIES
- LIST OF FIGURES
- FIGURE 1.KYPHOPLASTY MARKET SEGMENTATION
- FIGURE 2.KYPHOPLASTY MARKET,2021-2031
- FIGURE 3.KYPHOPLASTY MARKET,2021-2031
- FIGURE 4. TOP INVESTMENT POCKETS, BY REGION
- FIGURE 5.PORTER FIVE-1
- FIGURE 6.PORTER FIVE-2
- FIGURE 7.PORTER FIVE-3
- FIGURE 8.PORTER FIVE-4
- FIGURE 9.PORTER FIVE-5
- FIGURE 10.TOP PLAYER POSITIONING
- FIGURE 11.KYPHOPLASTY MARKET:DRIVERS, RESTRAINTS AND OPPORTUNITIES
- FIGURE 12.KYPHOPLASTY MARKET,BY PRODUCT,2021(%)
- FIGURE 13.COMPARATIVE SHARE ANALYSIS OF KYPHOPLASTY SYSTEMS KYPHOPLASTY MARKET,2021-2031(%)
- FIGURE 14.COMPARATIVE SHARE ANALYSIS OF ACCESSORIES KYPHOPLASTY MARKET,2021-2031(%)
- FIGURE 15.KYPHOPLASTY MARKET,BY INDICATION,2021(%)
- FIGURE 16.COMPARATIVE SHARE ANALYSIS OF OSTEOPOROSIS KYPHOPLASTY MARKET,2021-2031(%)
- FIGURE 17.COMPARATIVE SHARE ANALYSIS OF OTHERS KYPHOPLASTY MARKET,2021-2031(%)
- FIGURE 18.KYPHOPLASTY MARKET,BY END USER,2021(%)
- FIGURE 19.COMPARATIVE SHARE ANALYSIS OF HOSPITALS AND CLINICS KYPHOPLASTY MARKET,2021-2031(%)
- FIGURE 20.COMPARATIVE SHARE ANALYSIS OF AMBULATORY SURGICAL CENTERS KYPHOPLASTY MARKET,2021-2031(%)
- FIGURE 21.KYPHOPLASTY MARKET BY REGION,2021
- FIGURE 22.U.S. KYPHOPLASTY MARKET,2021-2031($MILLION)
- FIGURE 23.CANADA KYPHOPLASTY MARKET,2021-2031($MILLION)
- FIGURE 24.MEXICO KYPHOPLASTY MARKET,2021-2031($MILLION)
- FIGURE 25.GERMANY KYPHOPLASTY MARKET,2021-2031($MILLION)
- FIGURE 26.FRANCE KYPHOPLASTY MARKET,2021-2031($MILLION)
- FIGURE 27.U.K. KYPHOPLASTY MARKET,2021-2031($MILLION)
- FIGURE 28.ITALY KYPHOPLASTY MARKET,2021-2031($MILLION)
- FIGURE 29.SPAIN KYPHOPLASTY MARKET,2021-2031($MILLION)
- FIGURE 30.REST OF EUROPE KYPHOPLASTY MARKET,2021-2031($MILLION)
- FIGURE 31.JAPAN KYPHOPLASTY MARKET,2021-2031($MILLION)
- FIGURE 32.CHINA KYPHOPLASTY MARKET,2021-2031($MILLION)
- FIGURE 33.AUSTRALIA KYPHOPLASTY MARKET,2021-2031($MILLION)
- FIGURE 34.INDIA KYPHOPLASTY MARKET,2021-2031($MILLION)
- FIGURE 35.SOUTH KOREA KYPHOPLASTY MARKET,2021-2031($MILLION)
- FIGURE 36.REST OF ASIA-PACIFIC KYPHOPLASTY MARKET,2021-2031($MILLION)
- FIGURE 37.BRAZIL KYPHOPLASTY MARKET,2021-2031($MILLION)
- FIGURE 38.SAUDI ARABIA KYPHOPLASTY MARKET,2021-2031($MILLION)
- FIGURE 39.SOUTH AFRICA KYPHOPLASTY MARKET,2021-2031($MILLION)
- FIGURE 40.REST OF LAMEA KYPHOPLASTY MARKET,2021-2031($MILLION)
- FIGURE 41. TOP WINNING STRATEGIES, BY YEAR
- FIGURE 42. TOP WINNING STRATEGIES, BY DEVELOPMENT
- FIGURE 43. TOP WINNING STRATEGIES, BY COMPANY
- FIGURE 44.PRODUCT MAPPING OF TOP 10 PLAYERS
- FIGURE 45.COMPETITIVE DASHBOARD
- FIGURE 46.COMPETITIVE HEATMAP OF TOP 10 KEY PLAYERS
- FIGURE 47.ALPHATEC HOLDINGS TNC.: NET SALES ,($MILLION)
- FIGURE 48.BENVENUE MEDICAL INC.: NET SALES ,($MILLION)
- FIGURE 49.GLOBUL MEDICAL INC.: NET SALES ,($MILLION)
- FIGURE 50.JHONSON AND JHONSON.: NET SALES ,($MILLION)
- FIGURE 51.MEDTRONIC.: NET SALES ,($MILLION)
- FIGURE 52.STRYKER.: NET SALES ,($MILLION)
- FIGURE 53.IZI MEDICA PRODUCTS.: NET SALES ,($MILLION)
- FIGURE 54.MERIT MEDICALS SYSTEMS.: NET SALES ,($MILLION)
- FIGURE 55.SWAWON MEDITECH.: NET SALES ,($MILLION)
Research Assistance
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook